HNF4alpha Dysfunction and Cyclosporine Induced Hypertension
Author Information
Author(s): Monika Niehof, Jürgen Borlak
Primary Institution: Center of Molecular Medicine and Medical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany
Hypothesis
The study investigates the effect of cyclosporine on HNF4alpha expression and its role in hypertension.
Conclusion
Cyclosporine represses HNF4alpha activity, leading to a disturbed balance of the renin-angiotensin system and resulting in hypertension.
Supporting Evidence
- Cyclosporine treatment significantly reduced the expression of HNF4alpha and its target genes.
- The study identified angiotensin II receptor type 1, ACE, and ACE2 as genes targeted by HNF4alpha.
- HNF4alpha DNA-binding activity was inhibited by cyclosporine, affecting gene expression in the renin-angiotensin system.
Takeaway
Cyclosporine, a drug used to prevent organ rejection, can cause high blood pressure by affecting a protein called HNF4alpha, which helps control blood pressure.
Methodology
The study used human hepatoma cells treated with cyclosporine to analyze gene expression and protein activity related to the renin-angiotensin system.
Statistical Information
P-Value
0.0014
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website